Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.
Kuprash DV, Alimzhanov MB, Tumanov AV, Grivennikov SI, Shakhov AN, Drutskaya LN, Marino MW, Turetskaya RL, Anderson AO, Rajewsky K, Pfeffer K, Nedospasov SA. Kuprash DV, et al. Among authors: nedospasov sa. Mol Cell Biol. 2002 Dec;22(24):8626-34. doi: 10.1128/MCB.22.24.8626-8634.2002. Mol Cell Biol. 2002. PMID: 12446781 Free PMC article.
Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects.
Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Förster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA. Grivennikov SI, et al. Among authors: nedospasov sa. Immunity. 2005 Jan;22(1):93-104. doi: 10.1016/j.immuni.2004.11.016. Immunity. 2005. PMID: 15664162 Free article.
Tumor necrosis factor, lymphotoxin and cancer.
Drutskaya MS, Efimov GA, Kruglov AA, Kuprash DV, Nedospasov SA. Drutskaya MS, et al. Among authors: nedospasov sa. IUBMB Life. 2010 Apr;62(4):283-9. doi: 10.1002/iub.309. IUBMB Life. 2010. PMID: 20155809 Free article. Review.
Making anti-cytokine therapy more selective: Studies in mice.
Drutskaya MS, Efimov GA, Astrakhantseva IV, Kruglov AA, Nedospasov SA. Drutskaya MS, et al. Among authors: nedospasov sa. Cytokine. 2018 Jan;101:33-38. doi: 10.1016/j.cyto.2016.08.022. Epub 2016 Sep 10. Cytokine. 2018. PMID: 27624866 Review.
Tumor Necrosis Factor and the consequences of its ablation in vivo.
Efimov GA, Kruglov AA, Tillib SV, Kuprash DV, Nedospasov SA. Efimov GA, et al. Among authors: nedospasov sa. Mol Immunol. 2009 Nov;47(1):19-27. doi: 10.1016/j.molimm.2009.01.007. Epub 2009 Feb 23. Mol Immunol. 2009. PMID: 19230974 Review.
Can we design a better anti-cytokine therapy?
Drutskaya MS, Efimov GA, Kruglov AA, Nedospasov SA. Drutskaya MS, et al. Among authors: nedospasov sa. J Leukoc Biol. 2017 Sep;102(3):783-790. doi: 10.1189/jlb.3MA0117-025R. Epub 2017 May 25. J Leukoc Biol. 2017. PMID: 28546502 Review.
275 results